van Leenders GJLH - Search Results

1

Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study.

Rijksen BLT, Pos FJ, Hulshof MCCM, Vernooij RWM, Jansen H, van Andel G, Wijsman BP, Somford DM, Busstra MB, van Moorselaar RJA, Kaa CAH, van Leenders GJLH, Hamberg P, van den Berkmortel F, Fütterer JJ, Kiemeney LA, van Oort IM, Aben KKH. Rijksen BLT, et al. Among authors: van oort im, van andel g, van den berkmortel f, van moorselaar rja, van leenders gjlh. Eur Urol Focus. 2021 Mar;7(2):332-339. doi: 10.1016/j.euf.2019.11.005. Epub 2019 Nov 17. Eur Urol Focus. 2021. PMID: 31748122 Review.

2

The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.

Sedelaar JP, Aarnink RG, van Leenders GJ, Beerlage HP, Debruyne FM, Wijkstra H, de La Rosette JJ. Sedelaar JP, et al. Eur Urol. 2000 May;37(5):559-68. doi: 10.1159/000020193. Eur Urol. 2000. PMID: 10765094

3

Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer.

Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, van der Poel HG, van der Laak JA, Debruyne FM, Wijkstra H, de la Rosette JJ. Sedelaar JP, et al. Eur Urol. 2001 Sep;40(3):285-93. doi: 10.1159/000049788. Eur Urol. 2001. PMID: 11684844

4

The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer.

Goossen TE, de la Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H. Goossen TE, et al. Eur Urol. 2003 Feb;43(2):124-31. doi: 10.1016/s0302-2838(02)00582-1. Eur Urol. 2003. PMID: 12565769

5

Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.

van Leenders GJ, Dukers D, Hessels D, van den Kieboom SW, Hulsbergen CA, Witjes JA, Otte AP, Meijer CJ, Raaphorst FM. van Leenders GJ, et al. Eur Urol. 2007 Aug;52(2):455-63. doi: 10.1016/j.eururo.2006.11.020. Epub 2006 Nov 17. Eur Urol. 2007. PMID: 17134822

6

Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screening.

Postma R, Schröder FH, van Leenders GJ, Hoedemaeker RF, Vis AN, Roobol MJ, van der Kwast TH. Postma R, et al. Eur Urol. 2007 Jul;52(1):89-97. doi: 10.1016/j.eururo.2007.01.030. Epub 2007 Jan 16. Eur Urol. 2007. PMID: 17257742 Clinical Trial.

7

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.

van Roermund JG, Kok DE, Wildhagen MF, Kiemeney LA, Struik F, Sloot S, van Oort IM, Hulsbergen-van de Kaa CA, van Leenders GJ, Bangma CH, Witjes JA. van Roermund JG, et al. BJU Int. 2009 Aug;104(3):321-5. doi: 10.1111/j.1464-410X.2009.08404.x. Epub 2009 Feb 11. BJU Int. 2009. PMID: 19220264

8

Reduction of serum prostate-specific antigen levels following varicella-zoster infection and valaciclovir treatment in prostate cancer.

Jurhill RR, van der Veen H, van Leenders GJ, Verhagen PC. Jurhill RR, et al. Eur Urol. 2009 Aug;56(2):392-4. doi: 10.1016/j.eururo.2009.02.025. Epub 2009 Feb 28. Eur Urol. 2009. PMID: 19278776

9

Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer.

Wolters T, Roobol MJ, van Leeuwen PJ, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, Schröder FH, van der Kwast TH. Wolters T, et al. Eur Urol. 2010 May;57(5):821-9. doi: 10.1016/j.eururo.2009.07.027. Epub 2009 Jul 29. Eur Urol. 2010. PMID: 19664875

10

Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test.

Roobol MJ, Schröder FH, van Leeuwen P, Wolters T, van den Bergh RC, van Leenders GJ, Hessels D. Roobol MJ, et al. Eur Urol. 2010 Oct;58(4):475-81. doi: 10.1016/j.eururo.2010.06.039. Epub 2010 Jul 9. Eur Urol. 2010. PMID: 20637539 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page